Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | +4.95% | +21.14% | +4.95% |
13/03 | Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.95% | 52.05M | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- AADI Stock
- News Aadi Bioscience, Inc.
- Aadi Bioscience's Fyarro Gets FDA Approval to Treat Certain Cell Tumor Patients; Shares Climb